Roche criticised for refusing access to flu drug data

Clinical study reports – rather than just cherry-picked published research – should be publicly available for all drugs, the reviewers, including Australian evidence-based medicine expert Professor Chris Del Mar, contended in a paper published online in PLoS Medicine.

Clinical study reports were much larger, far more detailed and were used by regulators to determine whether to register a new drug, they said.

When the panel for the Cochrane review of neuraminidase inhibitors read the study reports on Tamiflu,